Current liabilities increased 19.5%
Current liabilities changed +19.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +19.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +520 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +143.2% from the comparable as-filed period.
Shares outstanding changed -7.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Net income changed +97.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +19.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -26.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -15.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +13.1% from the comparable as-filed period.
Operating cash flow / net income changed -50.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -1064 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -385 basis points from the comparable as-filed period.
Free-cash-flow margin changed -396 basis points from the comparable as-filed period.
Gross margin changed +108 basis points from the comparable as-filed period.
Receivables / revenue changed +480 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -3.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +14.6% from the comparable as-filed period.
Current assets changed -8.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current ratio changed -23.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -2.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capital expenditure changed +23.4% from the comparable as-filed period.
Stock-based compensation changed +11.0% from the comparable as-filed period.
Research & development changed +6.1% from the comparable as-filed period.
Cost of revenue changed +7.0% from the comparable as-filed period.
Capex / revenue changed +10 basis points from the comparable as-filed period.
R&D / revenue changed -89 basis points from the comparable as-filed period.
SBC / revenue changed -21 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +71.5% from the comparable as-filed period.
Operating cash flow changed +63.1% from the comparable as-filed period.
Shares outstanding changed -6.8% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Cash & equivalents changed +156.0% from the comparable as-filed period.
Current assets changed +89.9% from the comparable as-filed period.
Total assets changed +60.7% from the comparable as-filed period.
Stockholders' equity changed -85.7% from the comparable as-filed period.
Working capital changed +393.3% from the comparable as-filed period.
Revenue changed +11.4% from the comparable as-filed period.
Free-cash-flow margin changed +570 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +521 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -71 basis points from the comparable as-filed period.
Operating cash flow / net income changed +81.3% from the comparable as-filed period.
Current liabilities changed +15.7% from the comparable as-filed period.
Current ratio changed +64.2% from the comparable as-filed period.
Working capital / assets changed +2307 basis points from the comparable as-filed period.
Receivables / revenue changed -414 basis points from the comparable as-filed period.
Capital expenditure changed -69.7% from the comparable as-filed period.
Gross margin changed -33 basis points from the comparable as-filed period.
Stock-based compensation changed +16.9% from the comparable as-filed period.
Net income changed -10.0% from the comparable as-filed period.
Gross profit changed +11.0% from the comparable as-filed period.
Cost of revenue changed +13.5% from the comparable as-filed period.
R&D / revenue changed -162 basis points from the comparable as-filed period.
Operating income changed +2.5% from the comparable as-filed period.
Trade receivables changed +6.3% from the comparable as-filed period.
Capex / revenue changed -49 basis points from the comparable as-filed period.
Research & development changed -1.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +53 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.